IA
AXSM icon

IFP Advisors’s Axsome Therapeutics AXSM Stock Holding History

IFP Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.2M Buy
62,273
+1,279
+2% +$277K 0.28% 72
2026
Q1 		$10.3M Sell
60,994
-1,454
-2% -$251K 0.21% 98
2025
Q4 		$11.4M Sell
62,448
-865
-1% -$121K 0.26% 76
2025
Q3 		$7.69M Sell
63,313
-705
-1% -$79.4K 0.2% 105
2025
Q2 		$6.68M Sell
64,018
-4,096
-6% -$434K 0.19% 111
2025
Q1 		$7.94M Buy
68,114
+275
+0.4% +$31.3K 0.25% 88
2024
Q4 		$5.74M Buy
67,839
+18,038
+36% +$1.66M 0.19% 112
2024
Q3 		$4.48M Buy
+49,801
New +$4.35M 0.16% 137
2022
Q4 		– Sell
-200
Closed -$4K – 4608
2022
Q3 		$4K Buy
+200
New +$9.99K ﹤0.01% 4089
2022
Q1 		– Sell
-10
Closed -$1K – 4544
2021
Q4 		$1K Hold
10
– – ﹤0.01% 2937
2021
Q3 		$1K Buy
+10
New +$390 ﹤0.01% 2976

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IFP Advisors's AXSM Position: Q2 2026 in Review

IFP Advisors increased its Axsome Therapeutics (AXSM) stake by 2.1% in Q2 2026, buying an estimated $277K and bringing the position to 62,273 shares worth $15.2M. The position accounts for 0.28% of the portfolio, ranked #72.

IFP Advisors first reported a position in AXSM in Q3 2021 and has held it in 11 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • IFP Advisors held 62,273 shares of Axsome Therapeutics worth $15.2M as of Q2 2026.
  • IFP Advisors bought 1,279 Axsome Therapeutics shares in Q2 2026, an estimated $277K.
  • Axsome Therapeutics made up 0.28% of IFP Advisors's portfolio in Q2 2026, its #72 holding.
  • IFP Advisors first reported a position in Axsome Therapeutics in Q3 2021 and has held it in 11 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.